Ortho Clinical Diagnostics Holdings plc P/E Ratio

Ortho Clinical Diagnostics Holdings plc (OCDX) currently reports a P/E ratio of -80.14. That is below the Healthcare sector average of 25.3. Use the charts on this page to explore Ortho Clinical Diagnostics Holdings plc's P/E ratio history and peer comparisons.

Ortho Clinical Diagnostics Holdings plc's P/E ratio of -80.14 is lower than the Healthcare sector average of 25.3. That is roughly 416.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Ortho Clinical Diagnostics Holdings plc's market price to a fundamental measure such as earnings, sales, or book value. At -80.14, OCDX can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -80.14, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.3. From there, open related valuation or income-statement pages for Ortho Clinical Diagnostics Holdings plc, and consider following OCDX for alerts when major investors trade the stock.

Ortho Clinical Diagnostics Holdings plc is classified in the Healthcare sector. On P/E ratio, it currently shows -80.14 versus a sector average near 25.3. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OCDX with unrelated industries.